101730.KQ Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg's Top 50
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
00:41
May 28
Obesity drug data very strong.
DND Pharmatech released strong 48-week phase 2 data for its obesity drug DD01, which drove a limit-up and continued rally, signaling significant pipeline value.
MED

About 101730.KQ Analyst Coverage

Buzzberg tracks 101730.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.